Global Healthcare Analyst

Tina Banerjee

Equity Capital Markets

Distinct Healthcare Holdings / Equity Capital Markets

<ul>
<li>Distinct Healthcare has launched HK IPO consisting of 4.75M H shares at HK$57.70–66.60 per share. Subscriptions will close on February 3, with expected listing on February 6.</li>
<li>The company intends to use IPO proceeds for deploying advanced AI technologies to improve operational efficiency, upgrading existing healthcare service institutions and expand in new location, and inorganic growth.</li>
<li>Distinct Healthcare reported consistent growth and improving profitability mainly riding on ramping up of existing facilities. The company has built a growing patient base.</li>
</ul>


Distinct Healthcare has launched HK IPO consisting of 4.75M H shares at HK$57.70–66.60 per share. Subscriptions will close on February 3, with expected listing on February 6.
The company intends to use IPO proceeds for deploying advanced AI technologies to improve operational efficiency, upgrading existing healthcare service institutions and expand in new location, and inorganic growth.
Distinct Healthcare reported consistent growth and improving profitability mainly riding on ramping up of existing facilities. The company has built a growing patient base.


Distinct Healthcare IPO: Growing Patient Base to Drive Profitable Revenue Growth

HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

<ul>
<li>Due to industry characteristics, it would be difficult for Distinct Healthcare to scale up. The Company is more of “a supplementary role” in the entire medical service system in China.</li>
<li>Profit margin is not satisfactory and cost side is also difficult to reduce. Even if Distinct Healthcare successfully turns losses into profits, it’s hard to generate good returns for investors.</li>
<li>Post-Money valuation was US$510 million after Series E financing. For a company that would encounter bottlenecks in both revenue and profit growth, it would be difficult to achieve high valuation.</li>
</ul>


Due to industry characteristics, it would be difficult for Distinct Healthcare to scale up. The Company is more of “a supplementary role” in the entire medical service system in China.
Profit margin is not satisfactory and cost side is also difficult to reduce. Even if Distinct Healthcare successfully turns losses into profits, it’s hard to generate good returns for investors.
Post-Money valuation was US$510 million after Series E financing. For a company that would encounter bottlenecks in both revenue and profit growth, it would be difficult to achieve high valuation.


Pre-IPO Distinct Healthcare Holdings-  Hard to Deliver the Expected Returns Due to Growth Bottleneck

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Distinct Healthcare Holdings (DHH HK)

Distinct Healthcare IPO: Growing Patient Base to Drive Profitable Revenue Growth

Distinct Healthcare has launched HK IPO consisting of 4.75M H shares at a price range of HK$57.70–66.60 per share. Subscriptions will close on...

Tina Banerjee

Pre-IPO Distinct Healthcare Holdings- Hard to Deliver the Expected Returns Due to Growth Bottleneck

Distinct Healthcare faces challenges in scaling up due to industry characteristics and may not generate good returns for investors despite turning...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Distinct Healthcare IPO: Growing Patient Base to Drive Profitable Revenue Growth

Distinct Healthcare has launched HK IPO consisting of 4.75M H shares at a price range of HK$57.70–66.60 per share. Subscriptions will close on...

Tina Banerjee

Pre-IPO Distinct Healthcare Holdings- Hard to Deliver the Expected Returns Due to Growth Bottleneck

​Distinct Healthcare faces challenges in scaling up due to industry characteristics and may not generate good returns for investors despite turning...

Xinyao (Criss) Wang

Distinct Healthcare faces challenges in scaling up due to industry characteristics and may not generate good returns for investors despite turning...